Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis

被引:0
|
作者
Carrera, Jeanneth Elizabeth Jami [1 ]
Gavilanes, John Sebastian Carvajal [1 ]
Espin, Karen Gabriela Sulca [1 ]
Montenegro, Dennis Alexander Montenegro [1 ]
机构
[1] Univ Reg Autonoma los Andes, Ambato, Ecuador
来源
关键词
stevens-johnson syndrome; sepsis; keratinocytes;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Stevens-Johnson syndrome and toxic epidermal necrolysis are severe mucocutaneous rare diseases with high morbid mortality characterized by generalized epidermal necrosis and skin detachment; They are distinguished from each other due to the extent of skin that is affected. Drugs are the main trigger factor, usually in the first weeks of treatment. These pathologies can be fatal when more than 60 % of the body surface is affected. The objective of the research was to describe distinctive clinical characteristics, underlying triggers and main multisystem manifestations through an updated analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis. It is essential to optimize the prognosis and mitigate the possible complications associated with these medical conditions of high complexity.
引用
收藏
页码:1187 / 1194
页数:8
相关论文
共 50 条
  • [31] Ocular Involvement in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
    Chronopoulos, A.
    Pleyer, U.
    Mockenhaupt, M.
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2012, 229 (05) : 534 - 539
  • [32] Nevirapine and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis
    Fagot, JP
    Mockenhaupt, M
    Bouwes-Bavinck, JN
    Naldi, L
    Viboud, C
    Roujeau, JC
    AIDS, 2001, 15 (14) : 1843 - 1848
  • [33] Diagnosis and management of Stevens-Johnson syndrome toxic epidermal necrolysis
    Noe, Megan H.
    Micheletti, Robert G.
    CLINICS IN DERMATOLOGY, 2020, 38 (06) : 607 - 612
  • [34] Wound Management in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
    Jaller, Jose A.
    McLellan, Beth N.
    Balagula, Yevgeniy
    CURRENT DERMATOLOGY REPORTS, 2020, 9 (01) : 58 - 72
  • [35] STEVENS-JOHNSON SYNDROME/TOXIC EPIDERMAL NECROLYSIS IN THE SETTING OF CIRRHOSIS
    Piechocki, S.
    Zamora, K.
    McCormick, A.
    Engel, L. S.
    Ward, K.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2022, 70 (02) : 728 - 728
  • [36] Insights on afatinib and toxic epidermal necrolysis/Stevens-Johnson syndrome
    Castellana, Eleonora
    Chiappetta, Maria Rachele
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2025,
  • [37] Recurrence of Stevens-Johnson syndrome and toxic epidermal necrolysis in adults
    Lee, Haur Yueh
    Thirumoorthy, T.
    Lee, Haur Yueh
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB150 - AB150
  • [38] Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
    Lerch, Marianne
    Mainetti, Carlo
    Beretta-Piccoli, Benedetta Terziroli
    Harr, Thomas
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2018, 54 (01) : 147 - 176
  • [39] Immunologic Mediators in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
    Saeed, Hajirah N.
    Chodosh, James
    SEMINARS IN OPHTHALMOLOGY, 2016, 31 (1-2) : 85 - 90
  • [40] Recurrence of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Reply
    Finkelstein, Yaron
    Macdonald, Erin M.
    Juurlink, David N.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 312 (15): : 1591 - 1591